Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent

被引：0
|
作者：
M. Panisset
S. Gauthier
H. Moessler
M. Windisch
机构：
[1]  McGill Centre for Studies in Ageing,
[2] Montreal,undefined
[3] Canada,undefined
[4] EBEWE Arzneimittel GmbH,undefined
[5] Unterach,undefined
[6] and,undefined
[7] JSW Research,undefined
[8] Graz,undefined
[9] Austria,undefined
来源：
Journal of Neural Transmission | 2002年 / 109卷
关键词：
Keywords: Alzheimer's disease; Cerebrolysin; neurodegeneration; neurotrophic factors; peptide derivative.;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1089 / 1104
页数：15
相关论文
共 50 条
  • [1] Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent
    Panisset, M
    Gauthier, S
    Moessler, H
    Windisch, M
    JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (7-8) : 1089 - 1104
  • [2] Cerebrolysin in Alzheimer's disease: A Randomized, Double-blind, Placebo-controlled Trial with a Neurotrophic Agent
    Ruther, E.
    Kasper, S.
    Moessler, H.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 57 - 58
  • [3] Results of a randomized, double-blind, placebo-controlled trial with the neurotrophic compound cerebrolysin in Alzheimer's disease patients
    Alvarez, A
    Laredo, M
    Sampedro, C
    Cacabelos, R
    Couceiro, V
    Vargas, M
    Aleixandre, M
    Illescas, E
    Linares, C
    Granizo, E
    Moessler, H
    NEUROBIOLOGY OF AGING, 2004, 25 : S209 - S209
  • [4] A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease
    Bae, CY
    Cho, JY
    Cho, KH
    Oho, BH
    Choi, KG
    Lee, HS
    Jung, SP
    Kim, DH
    Choi, KD
    Cho, HS
    Lee, HT
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S2 - S2
  • [5] A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease
    Bae, CY
    Cho, CY
    Cho, K
    Oh, BH
    Choi, KG
    Lee, HS
    Jung, SP
    Kim, DH
    Lee, S
    Choi, GD
    Cho, H
    Lee, H
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (12) : 1566 - 1571
  • [6] Dose-response effects of cerebrolysin in Alzheimer's disease patients: A randomized, double-blind, placebo-controlled trial
    Alvarez, XA
    Cacabelos, R
    Vargas, M
    Aleixandre, M
    Linares, C
    Granizo, E
    Moessler, H
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S383 - S383
  • [7] A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
    Turner, R. Scott
    Thomas, Ronald G.
    Craft, Suzanne
    van Dyck, Christopher H.
    Mintzer, Jacobo
    Reynolds, Brigid A.
    Brewer, James B.
    Rissman, Robert A.
    Raman, Rema
    Aisen, Paul S.
    NEUROLOGY, 2015, 85 (16) : 1383 - 1391
  • [8] Estrogen for Alzheimer's disease in women - Randomized, double-blind, placebo-controlled trial
    Henderson, VW
    Paganini-Hill, A
    Miller, BL
    Elble, RJ
    Reyes, PF
    Shoupe, D
    McCleary, CA
    Klein, RA
    Hake, AM
    Farlow, MR
    NEUROLOGY, 2000, 54 (02) : 295 - 301
  • [9] A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease
    Sano, M.
    Bell, K. L.
    Galasko, D.
    Galvin, J. E.
    Thomas, R. G.
    van Dyck, C. H.
    Aisen, P. S.
    NEUROLOGY, 2011, 77 (06) : 556 - 563
  • [10] Cerebrolysin - Efficacy and safety in moderate to moderately severe Alzheimer's disease: Subgroup analysis of a randomized, double-blind, placebo-controlled trial
    Moessler, H
    Alvarez, AX
    Cacabelos, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S207 - S207
12345